Regional cerebral blood flow in normal individuals aged 40, 75 and 88 years studied by 99tcm-d, l-hmpao spet

Nuclear Medicine Communications

Volumn 22, Issue 7, 2001, Pages 741-746

  Larsson, A ^a   Skoog, I ^a   Aevarsson, O ^a   ÄRLIG, Å ^b   Jacobsson, L ^b   Larsson, L ^c   OSTLING S ^c   WikkelsO C ^c  

^a Institute of Clinical Neurosciences   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Normal ageing; Rcbf; SPET

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; BRAIN BLOOD FLOW; CEREBELLUM; CINGULATE GYRUS; COLLIMATOR; FEMALE; FRONTAL LOBE; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR CORTEX; NORMAL HUMAN; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; AGING; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; RADIOPHARMACEUTICALS; REFERENCE VALUES; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034952891     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200107000-00003     Document Type: Review

References (36)

1. Martin A, Friston K, Colebatch J, Frackowiak R. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 1991; 11: 684-689.
2. Meyer JS, Terayama Y, Takashima S. Cerebral circulation in the elderly. Cerebrovasc Brain Metab Rev 1993; 5: 122-146.
3. Shaw T, Mortel K, Meyer JS, Rogers RL, Hardenberg J, Cutaia MM. Cerebral blood flow changes in benign ageing and cerebrovascular disease. Neurology 1984; 34: 855-862.
4. Waldemar G. Functional brain imaging with SPET in normal aging and dementia. Cerebrovasc Brain Metab Rev 1995; 7: 89-130.
5. Claus JJ, Breteler MM, Hasan D et al. Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiol Aging 1998; 19(1): 57-64.
6. Hagstadius S, Risberg J. Regional cerebral blood flow characteristics and variations with age in resting normal subjects. Brain Cogn 1989; 10: 28-43.
7. 99mTc-HMPAO SPECT. Neuroradiology 1998; 40(7): 428-434.
8. Pantano P, Baron J-C, Lebrun-Grandie’ P, Duquesnoy N, Bousser M-G, Comar D. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 1994; 15(4): 635-641.
9. 99mTc-d, l-HMPAO and SPET of the brain in normal aging. J Cereb Blood Flow Metab 1991; 11: 508-521.
10. 99mTc-HMPAO SPET study. Eur J Nucl Med 1996; 23: 1329-1337.
11. Markus HS, Ring H, Kouris K, Costa DC. Alternations in regional cerebral blood flow, with increased temporal interhemispheric asymmetries, in the normal elderly: an HMPAO SPET study. Nucl Med Commun 1993; 14: 628-633.
12. Mozley PD, Sadek AM, Alavi A et al. Effects of aging on the cerebral distribution of technetium-99m-hexamethylpropylene amine oxime in healthy humans. Eur J Nucl Med 1997; 24: 754-761.
13. Fazekas JF, Klein J, Finnerty FA. Influence of age and vascular disease on cerebral hemodynamics and metabolism. Am J Med 1955; 18: 477-485.
14. Kety SS. Human cerebral blood flow and oxygen consumption as related to aging. J Chronic Dis 1956; 3: 478-486.
15. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980; 4: 727-736.
16. Devous M, Stokely E, Chehabi H, Bonte F. Normal distribution of regional cerebral blood flow measured by dynamic single-photon emission tomography. J Cereb Blood Flow Metab 1986; 6: 95-104.
17. Leenders K, Perani D, Lammertsma A et al. Cerebral blood flow, blood volume and oxygen utilization; normal values and effect of age. Brain 1990; 113: 27-47.
18. Marchal G, Rioux P, Petit-Taboue’ M-C et al. Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch Neurol 1992; 49: 1013-1020.
19. Melamed E, Lavy S, Bentin S, Cooper G, Rinot Y. Reduction in regional cerebral blood flow during normal aging in man. Stroke 1980; 11(1): 31-35.
20. Mortel KF, Marykay AP, Wood S et al. ProSPETive studies of cerebral perfusion and cognitive testing among elderly normal volunteers and subjects with ischemic vascular dementia and Alzheimer’s disease. Angiology 1994; 3: 171-180.
21. Geaney DP. Single photon emission tomography. In: Burns A, Levy R, eds. Dementia. London: Chapman & Hall, 1994: 437-456.
22. Rinder L, Roupe S, Steen B, Svanborg A. Seventy-year-old people in Gothenburg. A population study in an industrialized Swedish city. I. General presentation of the study. Acta Med Scand 1975; 198: 397-407.
23. Svanborg A. Seventy-year-old people in Gothenburg. A population study in an industrialized Swedish city. II. General presentation of social and medical conditions. Acta Med Scand Suppl 1977; 611: 3-37.
24. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328: 153-158.
25. Aevarsson O, Skoog I. Dementia disorders in a birth cohort followed from age 85 to 88. The influence of mortality, non-response and diagnostic change on prevalence. Int Psychogeriatr 1997; 9: 11-23.
26. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of subjects for the clinician. J Psychiatr Res 1975; 12: 189-198.
27. Larsson SA. Gamma camera emission tomography. Acta Radiol 1980; 363(suppl): 1-75.
28. Sörensen JA. Methods for quantitating radioactivity in vivo by external counting measurements. PhD thesis, University of Wisconsin, 1971.
29. 99mTc-HMPAO SPET. Nucl Med Commun 1994; 15: 814-823.
30. Claus JJ, van Harskamp F, Breteler MMB et al. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in subjects with Alzheimer’s disease: effects of region of interest selection. Eur J Nucl Med 1994; 21: 1044-1051.
31. 99mTc]-d, l-HM-PAO compared to xenon-133. J Cereb Blood Flow Metab 1988; 8: 69-81.
32. Burns A, Philpot MP, Costa DC, Ell PJ, Levy R. The investigation of Alzheimer’s disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1989; 52: 248-253.
33. 99mTc-HM-PAO in subjects with dementia (Alzheimer type and HIV) and Parkinson’s disease-initial results. J Cereb Blood Flow Metab 1988; 8(suppl): 109-115.
34. Calne DB, Eisen A, Meneilly G. Normal aging of the nervous system. Ann Neurol 1991; 30: 206-207.
35. Takada H, Nagata K, Hirata Y et al. Age-related decline of cerebral oxygen metabolism in normal population detected with positron emission tomography. Neurol Res 1992; 14(suppl): 128-131.
36. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986: 147-151.